Advertisement
YOU ARE HERE: LAT HomeCollections

Business Briefing / PHARMACEUTICALS

Drug OKd for brain disorder

August 16, 2008|From Times Wire Services

The first U.S. treatment to reduce involuntary movements caused by Huntington's disease, a genetic brain disorder, was approved by the Food and Drug Administration.

The FDA cleared Xenazine, a tablet made by closely held Prestwick Pharmaceuticals Inc.

Advertisement
Los Angeles Times Articles
|
|
|